Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers
Open Access
- 20 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 42 (1) , 66-71
Abstract
OBJECTIVE Platinum-based chemotherapy followed by surgical resection of residual masses has become the standard treatment of patients with primary mediastinal non-seminomatous germ cell tumours (NSGCTs). Persistent serum tumour marker (STM) elevation after chemotherapy usually indicates a poor prognosis. We retrospectively assessed surgical outcomes in patients with high STM levels after chemotherapy for primary mediastinal NSGCT. METHODS Between 1983 and 2010, residual tumour excision was performed in 21 patients, 20 men and one woman with a median age of 30 years (range: 19–49 years), with primary mediastinal NSGCTs and high STM levels after platinum-based chemotherapy, followed by second-line chemotherapy in 11 patients. RESULTS Alpha-fetoprotein was elevated in all 21 patients and β-human chorionic gonadotropin in three patients. Permanent histology demonstrated viable germ cell tumour (n = 13), teratoma (n = 3) or necrosis (n = 5). After surgery, the STM levels returned to normal in 11 patients. Eight patients are alive with a median follow-up of 98 months. The 5-year survival rate was 36% and was not significantly affected by the use of preoperative second-line chemotherapy. At univariate analysis, only postoperative STM elevation and residual viable tumour, indicating incomplete resection, were significantly associated with lower survival (P = 0.018 and P = 0.04, respectively). CONCLUSION In patients with primary mediastinal NSGCTs and elevated post-chemotherapy STMs, surgery is warranted when complete resection is deemed feasible. In specialized oncology centres, this aggressive approach can provide a cure in some patients.Keywords
This publication has 21 references indexed in Scilit:
- Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer CenterJournal of Thoracic Oncology, 2011
- Advances in lung transplantation for cystic fibrosis that may improve outcomeEuropean Journal of Cardio-Thoracic Surgery, 2010
- Long-term outcome of double-lung and heart–lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients☆European Journal of Cardio-Thoracic Surgery, 2010
- Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapyAnnals of Oncology, 2009
- A 25-Year Single Institution Experience With Surgery for Primary Mediastinal Nonseminomatous Germ Cell TumorsThe Annals of Thoracic Surgery, 2008
- Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: Analysis of a single-institution experienceThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Outcome of Patients With Residual Germ Cell or Non-Germ Cell Malignancy After Resection of Primary Mediastinal Nonseminomatous Germ Cell CancerJournal of Clinical Oncology, 2004
- Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International AnalysisJournal of Clinical Oncology, 2002
- Primary mediastinal nonseminomatous germ cell tumors: The influence of postchemotherapy pathology on long-term survival after surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Clamshell or sternotomy for double lung or heart-lung transplantation?1European Journal of Cardio-Thoracic Surgery, 1999